Markets:

Overview

News

Currencies

International

Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

17.60 -0.43 (-2.38%)

Streaming Delayed Price Updated: 12:28 PM EDT, Jul 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

3 Overrated Stocks Walking a Fine Line

June 30, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm

June 29, 2026

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

Via StockStory

Stocks making big moves yesterday: Fortrea, Kura Sushi, Energizer, Bath and Body Works, and Robinhood

June 25, 2026

Check out the companies making headlines yesterday: Fortrea (NASDAQ:FTRE): Clinical research company Fortrea Holdings (NASDAQ:FTRE) rose by 4.6% on Wednesday...

Via StockStory

Why Fortrea (FTRE) Stock Is Trading Up Today

June 24, 2026

What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.6% in the morning session after Barclays raised its price target o...

Via StockStory

Topics Earnings Initial Public Offering

Fortrea (NASDAQ:FTRE) Beats on Q1 Profit but Revenue Miss Caps Gains ↗

May 05, 2026

Via Chartmill

3 Cash-Producing Stocks with Warning Signs

June 17, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

3 Unpopular Stocks We’re Skeptical Of

June 16, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

1 Unprofitable Stock to Research Further and 2 We Question

June 15, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

3 Overrated Stocks We Approach with Caution

May 29, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1

May 24, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...

Via StockStory

Fortrea’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 12, 2026

Fortrea’s first quarter results were well received by investors, as the company exceeded Wall Street expectations on both revenue and non-GAAP earnings. Mana...

Via StockStory

Topics Earnings

FTRE Q1 Deep Dive: Fortrea’s Commercial Momentum and Technology Focus Drive Margin Improvement

May 06, 2026

Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q1 CY2026 results topping the market’s revenue expectations, but sales fell by 2.3% year on...

Via StockStory

Fortrea (FTRE) Shares Skyrocket, What You Need To Know

May 05, 2026

What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 20.3% in the morning session after it reported first-quarter 2026 re...

Via StockStory

Topics Initial Public Offering

Fortrea (FTRE) Q1 2026 Earnings Transcript ↗

May 05, 2026

Fortrea (FTRE) Q1 2026 Earnings Transcript

Via The Motley Fool

Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars

May 05, 2026

Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.3% year on year to $636.5 m...

Via StockStory

Topics Earnings

Fortrea (FTRE) Q1 Earnings: What To Expect

May 03, 2026

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings this Tuesday before market open. Here’s what to look for. Fortrea missed ...

Via StockStory

Topics Artificial Intelligence

3 Small-Cap Stocks with Questionable Fundamentals

May 01, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

2 of Wall Street’s Favorite Stocks to Consider Right Now and 1 We Question

April 22, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

Topics Artificial Intelligence

3 Reasons to Avoid FTRE and 1 Stock to Buy Instead

April 14, 2026

Fortrea has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $9.39. Is there a buying opportunity in Fortr...

Via StockStory

Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know

April 07, 2026

What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...

Via StockStory

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

April 06, 2026

What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci...

Via StockStory

Topics Government Stocks

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Government Stocks

1 Healthcare Stock to Consider Right Now and 2 We Turn Down

March 25, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial ...

Via StockStory

Why Fortrea (FTRE) Stock Is Up Today

March 18, 2026

What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 2.8% in the afternoon session after TD Cowen upgraded the company to...

Via StockStory

Topics Economy Initial Public Offering Stocks

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

March 16, 2026

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...

Via StockStory

Topics Economy Stocks

3 Small-Cap Stocks with Open Questions

March 12, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

3 Stocks Under $50 Walking a Fine Line

March 09, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know

March 06, 2026

Via StockStory

Topics Economy

Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 03, 2026

Via StockStory

Fortrea (FTRE) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Fortrea (FTRE) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.